✦ LIBER ✦

Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluorouracil in patients with unresectable biliary tract tumors

✍ Scribed by Maurizio Cantore; Andrea Mambrini; Giammaria Fiorentini; Carla Rabbi; Donatella Zamagni; Roberto Caudana; Cristina Pennucci; Franco Sanguinetti; Mirko Lombardi; Nicola Nicoli

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 78 KB
Volume: 103
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.20964

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of 5-fluorouracil, leuc

A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinoma

✍ Pedro M. Sanz-Altamira; Karen Ferrante; Roger L. Jenkins; W. David Lewis; Mark S 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 2 views

## Background: Unresectable adenocarcinoma of the biliary tree are associated with a very poor prognosis. 5-fluorouracil (5-fu) combination regimens have produced objective response rates in approximately 10-20% of patients. leucovorin increases the selective cytotoxicity of 5-fu. there also are en

A phase 1 study of hepatic arterial infu

A phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liver

✍ Apostolia M. Tsimberidou; Siqing Fu; Chaan Ng; Jo Ann Lim; Sijin Wen; David Hong 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 254 KB 👁 1 views

A phase II evaluation of a 3-hour infusi

A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck : Southwest Oncology Group study 0007

✍ Francis P. Worden; James Moon; Wolfram Samlowski; Joseph I. Clark; Shaker R. Dak 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 1 views